“…5,6 Therefore, Nrf2 is a potential target for many chronic diseases, such as chronic kidney disease, asthma, neurodegenerative diseases, and cancer. [7][8][9][10][11][12][13] It is known that small molecules Nrf2 activators, such as sulforaphane (SFN), 14 curcumin, 15 and chalcone derivatives, 16 have been identified as cancer chemopreventive agents. Screening for Nrf2 activators would lead to the discovery of new pharmaceuticals for oxidative stress-associated chronic diseases.…”